STAAR Surgical (STAA) Swings To Profit On China Rebound

finance.yahoo.com · 2026-09-14

On August 12, STAAR Surgical (NASDAQ:STAA) reported results for the quarter ended July 3 that flipped the script from a year earlier. Net sales jumped 111% year over year to $93.5 million, and the company that lost money in the same quarter of 2025 turned in $8.1 million of net income instead. It is the […]

TickrTrends take: STAAR Surgical's return to profitability, driven by recovery in its China market, provides concrete earnings improvement that supports TickrTrends' undervalued assessment for the healthcare device maker. Investors focused on valuation metrics should monitor whether this China rebound sustains and translates into consistent margin expansion, as the company's profitability trajectory will be key to justifying any valuation multiple re-rating. The timing of improved China performance is particularly relevant given the company's prior exposure to regional headwinds, making verification of sustainable demand recovery essential for assessing whether current pricing reflects fair value.

Read the full story at finance.yahoo.com →